http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019004980-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026c8f18d6b731e74f69f478a4eaafae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fffe6f0c20db6722d9441cd6496779e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f85564418d5538590b43888e73e2dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6030e596e59c47263cb82066bc6f28b0
publicationDate 2019-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019004980-A3
titleOfInvention SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE
abstract The present invention relates to solid oral pharmaceutical compositions comprising dabigatran esterxilate in the form of the free base or in the form of pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters thereof. .
priorityDate 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012001156-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2929884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013124340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016142821-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565674

Total number of triples: 31.